Developments in Treatment of Parkinson’s Disease
This past year brought several exciting developments in the treatment of Parkinson’s disease. From fast-tracking of an antibody being trialed as an immunotherapy drug in cancer treatment to FDA approval of the first medication to treat PD psychosis, researchers are advancing new medications for motor and secondary symptoms of the disease and gaining greater understanding of and potential therapies to slow disease process.
